Premium
Prerequisites to Implementing a Pharmacogenomics Program in a Large Health‐Care System
Author(s) -
Levy K D,
Decker B S,
Carpenter J S,
Flockhart D A,
Dexter P R,
Desta Z,
Skaar T C
Publication year - 2014
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2014.101
Subject(s) - pharmacogenomics , clinical pharmacology , personalized medicine , lagging , health care , key (lock) , medicine , medical education , computer science , pharmacology , bioinformatics , political science , biology , computer security , pathology , law
Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health‐care system. Clinical Pharmacology & Therapeutics (2014); 96 3, 307–309. advance online publication 11 June 2014. doi: 10.1038/clpt.2014.101